Cardiovascular disease risk profile and management among people 40 years of age and above in Bo, Sierra Leone: A cross-sectional study

listen audio

Study Justification:
The study aimed to assess the need and access to care for cardiovascular disease risk factors (CVDRFs) among individuals aged 40 and above in Bo, Sierra Leone. This is important because access to care for CVDRFs is limited in low- and middle-income countries, and understanding the current situation in Bo can help identify gaps and inform interventions to improve care.
Highlights:
– The majority of participants (94.0%) had low cardiovascular disease (CVD) risk.
– Based on WHO guidelines, 20.6% of participants required treatment for CVDRFs.
– Only 15.8% of participants had their treatment needs met according to WHO guidelines.
– Facility readiness scores for CVDRF care in Bo district were low (16.8%), compared to HIV care (41%).
Recommendations:
1. Improve access to care: Efforts should be made to ensure that individuals with CVDRFs have access to necessary treatments and services.
2. Enhance facility readiness: Investments should be made to improve the readiness of healthcare facilities in Bo district to provide quality care for CVDRFs.
3. Address equity in care: Strategies should be implemented to ensure that CVDRF care needs are met equitably, regardless of factors such as location, education, age, marital status, or wealth.
Key Role Players:
1. Ministry of Health: Responsible for policy development, resource allocation, and coordination of healthcare services.
2. Health facility administrators: Oversee the operations of healthcare facilities and implement changes to improve CVDRF care.
3. Healthcare providers: Including doctors, nurses, and other healthcare professionals who deliver care to individuals with CVDRFs.
4. Community leaders: Play a role in raising awareness, promoting healthy behaviors, and facilitating access to care in their communities.
Cost Items for Planning Recommendations:
1. Training and capacity building: Budget for training healthcare providers on CVDRF management and treatment guidelines.
2. Infrastructure improvement: Allocate funds for upgrading healthcare facilities to ensure they have the necessary equipment and amenities for CVDRF care.
3. Medications and supplies: Include the cost of medications, diagnostic tests, and other supplies needed for CVDRF management.
4. Public awareness campaigns: Allocate funds for community education and awareness programs to promote prevention and early detection of CVDRFs.
Please note that the cost items provided are general categories and the actual cost will depend on the specific context and resources available in Bo, Sierra Leone.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is based on a cross-sectional study and data from the WHO Service Availability and Readiness Assessment. The study provides detailed information on the need and access to care for cardiovascular disease risk factors in Bo, Sierra Leone. However, the evidence could be strengthened by including information on the sample size, sampling methodology, and statistical analysis methods used. Additionally, it would be helpful to provide more context on the limitations of the study and potential biases. To improve the evidence, future studies could consider using a longitudinal design to assess changes over time and include a larger and more diverse sample to enhance generalizability.

Introduction Access to care for cardiovascular disease risk factors (CVDRFs) in low- and middle-income countries is limited. We aimed to describe the need and access to care for people with CVDRF and the preparedness of the health system to treat these in Bo, Sierra Leone. Methods Data from a 2018 household survey conducted in Bo, Sierra Leone, was analysed. Demographic, anthropometric and clinical data on CVDRF (hypertension, diabetes mellitus or dyslipidaemia) from randomly sampled individuals 40 years of age and above were collected. Future risk of CVD was calculated using the World Health Organisation–International Society of Hypertension (WHO-ISH) calculator with high risk defined as >20% risk over 10 years. Requirement for treatment was based on WHO package of essential non-communicable (PEN) disease guidelines (which use a risk-based approach) or requiring treatment for individual CVDRF; whether participants were on treatment was used to determine whether care needs were met. Multivariable regression was used to test associations between individual characteristics and outcomes. Data from the most recent WHO Service Availability and Readiness Assessment (SARA) were used to create a score reflecting health system preparedness to treat CVDRF, and compared to that for HIV. Results 2071 individual participants were included. Most participants (n = 1715 [94.0%]) had low CVD risk; 423 (20.6%) and 431 (52.3%) required treatment based upon WHO PEN guidelines or individual CVDRF, respectively. Sixty-eight (15.8%) had met-need for treatment determined by WHO guidelines, whilst 84 (19.3%) for individual CVDRF. Living in urban areas, having education, being older, single/widowed/divorced, or wealthy were independently associated with met need. Overall facility readiness scores for CVD/CVDRF care for all facilities in Bo district was 16.8%, compared to 41% for HIV. Conclusion The number of people who require treatment for CVDRF in Sierra Leone is substantially lower based on WHO guidelines compared to CVDRF. CVDRF care needs are not met equitably, and facility readiness to provide care is low.

This is an analysis of the data from a 2018 household survey conducted in Bo, Sierra Leone and data from the most recent WHO Service Availability and Readiness Assessment (SARA) done in 2017 [2, 17]. Sierra Leone is located in West Africa. It is one of the least developed countries in the world. In 2017, the percentage of the gross domestic product (GDP) spent on health was 8.75% [18]. However, domestic general government health expenditure is only 1.23% of GDP; out of pocket (OOP) expenditure contributes 55.18% of total health expenditure and the external funding of health is high [18, 19]. The focus of external funding for health has been on communicable diseases, whereas NCDs (of which CVD and CVDRF are only a subset) received only $510,000 of a total of $170 million in 2017 [20, 21]. By contrast, HIV services received $30 million [20, 21]. The study was carried out in Bo district in the Southern province of Sierra Leone. It is the fifth most populous district in the country and comprises 15 rural chiefdoms and 24 urban areas [22]. Its district headquarters, Bo, is the second largest city in Sierra Leone [22]. The district has a recorded population of 575,478 constituting 8.1% of the country’s population with the majority living in rural areas (66.1%) [22]. Adults aged 40 years of age and above, among whom this study was done, comprise 17.4% of the total population [22]. In Bo district, healthcare is provided by a mix of public and private–for profit or not for profit–facilities at the primary or secondary healthcare levels [22]. The study sample included were men or women 40 years of age and above, this age group was selected given the increasing risk of CVDRF with age and to be congruent with other similar surveys [2, 23–26]. The surveys were developed in English, but translated into Mende or Krio by a bilingual speak, and back translated into English to check the accuracy of the translation. Numbers of participants to sample from urban and rural areas were calculated based on the proportions of people known to be living in these areas. The population in the area was not well delineated in census data, therefore sampling proceeded by first randomly selecting from rural chiefdoms or urban sub districts and, for the rural areas, by further randomly selecting villages or settlements from each chiefdom. Seven rural chiefdoms or urban sub districts were randomly selected to participate, and two settlements or villages were further randomly selected within each rural chiefdom. Data were collected electronically by trained data collectors using ODK software. Survey questions asked gender, age, marital status (as single, cohabiting, currently married, multiple partners, divorced, widowed, or refused), and highest level of education completed (no formal schooling, primary, junior secondary, senior secondary, higher education, or refused). There were 49 questions on house construction materials and household assets. Questions on smoking, awareness of presence of CVD or CVDRF, and whether respondents were on treatment for these risk factors were based on the WHO Stepwise survey; for those who reported suffering from a CVDRF, whether care had been accessed was asked. Blood pressure was measured in the seated position using an Omron M6 AC LED Monitor. Three measurements were taken five minutes apart. Blood samples were taken in the morning after an 8 hour overnight fast. Glucose and cholesterol were measured using the Accutrend® Plus Blood Test Meter (Diagnostics Roche) point of care device, with cholesterol being measured in every second participant. If participants reported not fasting prior to blood sampling, they were recorded as non-fasting. The conversion rate of 1.11 was used to convert capillary glucose to plasma glucose [27]. Glucose was measured in all participants, whilst due to resource constraints, cholesterol samples were obtained from every second participant. Age was used as a continuous variable or categorised into the following groups: 40–49, 50–59, 60–69, 70–79, and >80. Educational level was dichotomised as any completed education (primary or higher) or no completed education. Marital status was categorised as single/widowed/divorced or married/cohabiting. Wealth quintiles were derived using Filmer and Pritchetts’ method from the first principal component of household assets and construction materials [28]. Based on thresholds for individual CVDRF in use at the time of the study, having hypertension was defined as systolic blood pressure ≥ 140 or diastolic ≥ 90mmHg, calculated using the average of the final two BP readings, or being on treatment for hypertension in the past two weeks. Diabetes was defined as fasting plasma glucose (FPG) ≥7.0 mmol/L (126 mg/dL), or random plasma glucose (RPG) ≥11.1 mmol/L (200 mg/dL), or being on treatment for diabetes in the past 2 weeks. Dyslipidaemia was defined as measured total cholesterol level ≥ 6.21 mmol/L, or low-density lipoprotein (LDL) ≥ 4.1 mmol/L, or high-density lipoprotein (HDL) 20% risk as done in previous studies [33]. The WHO/ISH Risk score includes age, gender, smoking, diabetes, blood pressure, cholesterol and appropriate WHO epidemiological sub region [34]. Two secondary outcomes were studied–firstly the number of people who would require treatment for any CVDRF based on the WHO-PEN guidelines (which were available in 2018). WHO-PEN guidelines recommend treatment for hypertension if BP is ≥160/90mmHg or if BP is ≥140/90mmHg and CVD risk is >20%; treatment with hypoglycaemic agents is required if there is a diagnosis of diabetes; statin and aspirin treatment should be given if there is diabetes and a 10 year risk >20%, or 10 year risk is >30%; and ACE inhibitors should be given if diabetes is present and 10 year risk >20% (Appendix 2 in S1 File). The other secondary outcome was the number of people who would require treatment for the individual risk factors of diabetes, hypertension, or dyslipidaemia as defined by the study criteria, if a treat-to-target approach were used. Other outcomes describe access to care as the proportions of participants who required treatments under WHO-PEN guidelines and who were on those treatments and facility readiness to provide care. For the household survey, a sample size of 1893 participants was required to allow detection of diabetes prevalence (the risk factor thought likely to have the lowest prevalence) of 4% with a precision of ±1% [35]. To allow for non-response and non-availability of data, we oversampled by 20%. For the SARA survey, no sampling was done and all facilities in the district were included. WHO-risk scores were calculated using generated by the WHO/ISH Risk R-package [34]. For the household survey data, probability weights for age and sex in Bo were calculated from the 2015 Population and Household Census [22], and all analyses were done using weight adjustments. Continuous data are described as mean (SD) or median (IQR) if not normally distributed. Categorical variables are described as unweighted n and weighted %. For comparisons of continuous data we used t-tests or non-parametrics tests Mann-Whitney/ANOVA if data were skewed. Multivariable analyses of categorical outcomes were done using binary logistic regression. Age was not entered into the model assessing associations with high CVD risk, given its use in calculating the risk score. We did a complete case analysis for the multivariable analysis whilst the denominator for the univariate analysis varied. All analyses were done using SPSS V.26 (IBM). Ethical approval was sought and given from the Sierra Leone Ethical and Scientific Review Committee and the BDM Research Ethics sub-committee at King’s College London (HR-17/18-7298). Consent to undertake the study was obtained from each village chief or community leader. Consent was obtained from all individuals participating in the study. In the events were participants were illiterate, the consent form was read out to them in the local language and an inked-thumb signature obtained.

Based on the provided description, here are some potential innovations that could improve access to maternal health in Sierra Leone:

1. Mobile Health (mHealth) Solutions: Develop and implement mobile health applications that provide pregnant women and new mothers with access to information, resources, and support. These apps can provide guidance on prenatal care, nutrition, breastfeeding, and postpartum care.

2. Telemedicine: Establish telemedicine services that allow pregnant women in remote areas to consult with healthcare professionals through video calls. This can help address the shortage of healthcare providers in rural areas and provide timely advice and guidance.

3. Community Health Workers: Train and deploy community health workers who can provide basic prenatal and postnatal care, as well as education and support to pregnant women and new mothers in their communities. These workers can help bridge the gap between healthcare facilities and remote areas.

4. Maternal Health Vouchers: Introduce a voucher system that provides pregnant women with access to essential maternal health services, such as antenatal care, skilled birth attendance, and postnatal care. This can help reduce financial barriers and increase utilization of maternal health services.

5. Transportation Solutions: Improve transportation infrastructure and services to ensure that pregnant women can easily access healthcare facilities. This can include providing ambulances or other means of transportation for emergency situations and establishing referral systems between primary healthcare centers and hospitals.

6. Health Education Campaigns: Conduct targeted health education campaigns to raise awareness about the importance of maternal health and encourage women to seek timely care. These campaigns can be conducted through various channels, such as radio, television, community meetings, and mobile messaging.

7. Strengthening Health System Readiness: Invest in improving the readiness of healthcare facilities to provide quality maternal health services. This can include training healthcare providers, ensuring the availability of essential equipment and supplies, and improving the overall infrastructure of healthcare facilities.

It is important to note that these recommendations are based on the general context of improving access to maternal health and may need to be tailored to the specific needs and challenges faced in Sierra Leone.
AI Innovations Description
The analysis of the data from the household survey conducted in Bo, Sierra Leone highlights the limited access to care for cardiovascular disease risk factors (CVDRFs) in low- and middle-income countries. The study aimed to describe the need and access to care for people with CVDRFs and the preparedness of the health system to treat these conditions.

Based on the findings, here is a recommendation that can be developed into an innovation to improve access to maternal health:

1. Strengthen Primary Healthcare Facilities: Enhance the capacity of primary healthcare facilities in Bo, Sierra Leone to provide comprehensive maternal health services. This can be achieved by improving infrastructure, ensuring the availability of essential equipment and supplies, and training healthcare providers in maternal health care.

2. Increase Awareness and Education: Implement community-based awareness and education programs to increase knowledge about maternal health and the importance of seeking timely care. This can be done through community health workers, local leaders, and media campaigns to reach a wider audience.

3. Improve Referral Systems: Establish effective referral systems between primary healthcare facilities and higher-level healthcare facilities to ensure timely access to specialized care for high-risk pregnancies and complications. This can involve strengthening communication channels and providing transportation options for pregnant women in need of emergency care.

4. Enhance Antenatal Care Services: Focus on improving antenatal care services by providing comprehensive screenings for CVDRFs during pregnancy. This can help identify high-risk pregnancies and provide appropriate interventions to prevent complications.

5. Collaborate with International Organizations: Seek support and collaboration from international organizations and donors to allocate resources specifically for maternal health services in Sierra Leone. This can help address the funding gap and ensure sustainable improvements in access to care.

By implementing these recommendations, it is possible to develop innovative solutions that can improve access to maternal health services in Bo, Sierra Leone, and ultimately reduce maternal mortality and improve maternal and child health outcomes.
AI Innovations Methodology
The analysis you provided focuses on cardiovascular disease risk profile and management in Bo, Sierra Leone. To improve access to maternal health in this context, here are some potential recommendations:

1. Strengthening Primary Healthcare: Enhance the capacity of primary healthcare facilities in Bo, Sierra Leone to provide comprehensive maternal health services. This includes ensuring availability of skilled healthcare providers, essential medical equipment, and necessary medications.

2. Community-Based Interventions: Implement community-based interventions to raise awareness about maternal health and promote early antenatal care seeking. This can involve training community health workers to provide basic maternal health services, conducting health education sessions, and organizing mobile clinics in underserved areas.

3. Telemedicine and Mobile Health: Utilize telemedicine and mobile health technologies to improve access to maternal health services. This can involve providing remote consultations, sending health reminders and educational messages via mobile phones, and facilitating access to emergency obstetric care through telemedicine networks.

4. Transportation Support: Address transportation barriers by providing subsidized or free transportation services for pregnant women to reach healthcare facilities. This can include establishing community transport systems, partnering with local transportation providers, or utilizing ambulances for emergency cases.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could involve the following steps:

1. Baseline Data Collection: Gather data on the current state of maternal health access in Bo, Sierra Leone. This can include information on the number of pregnant women, utilization of antenatal care services, distance to healthcare facilities, and availability of skilled birth attendants.

2. Define Indicators: Identify key indicators to measure the impact of the recommendations. This can include indicators such as the number of pregnant women receiving antenatal care, the proportion of deliveries attended by skilled birth attendants, and the reduction in maternal mortality rates.

3. Modeling and Simulation: Use mathematical modeling techniques to simulate the impact of the recommendations on the defined indicators. This can involve creating a simulation model that incorporates factors such as population demographics, healthcare facility capacity, transportation infrastructure, and the effectiveness of the proposed interventions.

4. Sensitivity Analysis: Conduct sensitivity analysis to assess the robustness of the simulation results. This involves testing the model with different input parameters and scenarios to understand the potential variations in outcomes.

5. Evaluation and Refinement: Evaluate the simulation results and compare them with the baseline data. Identify gaps and areas for improvement in the proposed recommendations. Refine the model and interventions based on the findings to optimize the impact on improving access to maternal health.

It is important to note that the methodology described above is a general framework and may require customization based on the specific context and available data in Bo, Sierra Leone.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email